AXOGEN, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.66 USD | +0.45% |
|
-2.92% | -2.49% |
| 03-08 | Axogen Insider Sold Shares Worth $319,891, According to a Recent SEC Filing | MT |
| 03-08 | AxoGen, Inc. Announces Executive Changes | CI |
Chart calendar AxoGen, Inc.
84b31.xOkmLJi6jy2Z2hy23Wp5vA-4Go-QFc420n0zWhhlqQw.qrppW_eO3lryuSSOnwkX3WzaS9DefKlk4C4HPklX-z3wvxAdwdzBaK-YTQ~e5f9adcf7b0a64099258e8d98555ce9b
Upcoming events on AxoGen, Inc.
Past events on AxoGen, Inc.
| 05/03/2024 13:00 | Q4 2023 Earnings Call |
| 05/03/2024 12:00 | Q4 2023 Earnings Release |
| 30/11/2023 13:50 | Piper Sandler Healthcare Conference |
| 07/11/2023 13:00 | Q3 2023 Earnings Call |
| 07/11/2023 12:00 | Q3 2023 Earnings Release |
| 28/09/2023 13:35 | Cantor Global Healthcare Conference - Fireside Chat |
| 11/09/2023 13:30 | H.C. Wainwright Global Investment Conference |
| 15/08/2023 13:00 | Annual General Meeting |
| 09/08/2023 19:00 | Canaccord Genuity Growth Conference |
| 07/08/2023 21:30 | Q2 2023 Earnings Call |
| 07/08/2023 21:01 | Q2 2023 Earnings Release |
| 07/06/2023 13:30 | Jefferies Global Healthcare Conference |
| 15/05/2023 20:00 | JMP Securities Life Sciences Conference - Fireside Chat |
| 09/05/2023 13:00 | Q1 2023 Earnings Call |
| 09/05/2023 12:00 | Q1 2023 Earnings Release |
| 14/03/2023 12:00 | Q4 2022 Earnings Call |
| 14/03/2023 11:00 | Q4 2022 Earnings Release |
| 12/01/2023 17:45 | JP Morgan Healthcare Conference |
| 08/12/2022 19:45 | Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference |
| 30/11/2022 15:30 | Piper Sandler Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 107 107 0.11% | 112 111 1.44% | 127 128 -0.14% | 139 139 -0.03% | 159 157 1.22% | 179 |
|
EBITDA Million USD | Released Forecast Spread | -30,5 -27,7 -10% | -21,6 -13,0 -66.15% | -19,9 -18,4 -8.69% | -9,26 -11,6 20.52% | -1,12 -6,34 82.34% | 10,3 |
|
EBIT Million USD | Released Forecast Spread | -31,4 -30,6 -2.76% | -23,2 -22,3 -4.19% | -25,4 -28,0 9.09% | -29,7 -30,7 3.24% | -21,5 -24,4 11.92% | -15,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -29,1 -28,4 -2.69% | -23,8 -24,1 1.44% | -27,0 -30,1 10.45% | -28,9 -29,8 2.86% | -21,7 -24,8 12.41% | -18,0 |
|
Net income Million USD | Released Forecast Spread | -29,1 -28,4 -2.69% | -23,8 -23,7 -0.5% | -27,0 -30,1 10.45% | -28,9 -29,8 2.86% | -21,7 -24,3 10.5% | -18,6 |
|
EPS USD | Released Forecast Spread | -0,74 -0,72 -2.78% | -0,60 -0,61 0.83% | -0,65 -0,72 9.41% | -0,69 -0,71 2.13% | -0,51 -0,57 10% | -0,43 |
| Announcement Date | 24/02/20 | 22/02/21 | 22/02/22 | 14/03/23 | 05/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 31,5 31,6 -0.34% | 31,0 30,3 2.21% | 34,5 34,0 1.28% | 37,0 36,2 2% | 36,2 36,2 -0.09% | 36,7 35,5 3.4% | 38,2 39,1 -2.36% | 41,3 40,3 2.47% | 42,9 41,0 4.68% | 42,0 | 43,6 | 46,1 | 47,5 | 46,4 |
|
EBITDA Million USD | Released Forecast Spread | -3,67 -5,95 38.34% | -7,36 -6,00 -22.62% | -1,59 -4,52 64.85% | 0,37 -5,09 107.24% | -0,68 -3,09 77.9% | -3,79 -3,16 -19.97% | -0,25 -2,82 91.29% | 2,35 -0,41 681.23% | 0,57 -2,30 124.64% | -0,47 | 2,32 | 4,03 | 4,45 | |
|
EBIT Million USD | Released Forecast Spread | -5,35 -7,77 31.08% | -11,3 -7,93 -42.7% | -7,92 -7,96 0.51% | -4,86 -7,21 32.63% | -5,61 -6,63 15.47% | -7,34 -9,16 19.89% | -6,90 -8,28 16.68% | -4,03 -6,53 38.35% | -3,19 -6,08 47.49% | -5,69 | -4,55 | -3,05 | -2,32 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,29 -8,30 36.31% | -11,5 -8,57 -33.96% | -7,74 -8,21 5.78% | -4,32 -7,51 42.48% | -5,42 -6,25 13.36% | -7,07 -9,40 24.72% | -6,66 -8,48 21.5% | -4,09 -6,58 37.85% | -3,89 -6,98 44.25% | -6,24 | -5,10 | -3,65 | -2,97 | |
|
Net income Million USD | Released Forecast Spread | -5,29 -8,30 36.31% | -11,5 -8,82 -30.04% | -7,74 -8,41 8.02% | -4,32 -7,51 42.48% | -5,42 -6,25 13.36% | -7,07 -9,40 24.72% | -6,66 -8,48 21.5% | -4,09 -6,29 34.95% | -3,89 -6,46 39.69% | -5,99 | -5,27 | -4,06 | -3,31 | |
|
EPS USD | Released Forecast Spread | -0,13 -0,20 33.9% | -0,27 -0,21 -28.57% | -0,18 -0,20 11.11% | -0,10 -0,17 40.3% | -0,13 -0,15 10.34% | -0,17 -0,22 23.88% | -0,16 -0,20 18.65% | -0,10 -0,15 31.82% | -0,09 -0,15 38.64% | -0,14 | -0,12 | -0,09 | -0,08 | |
| Announcement Date | 22/02/22 | 04/05/22 | 03/08/22 | 08/11/22 | 14/03/23 | 09/05/23 | 07/08/23 | 07/11/23 | 05/03/24 | - | - | - | - | - |
| Today 11:20 | GE HEALTHCARE TECHNOLOGIES INC.: Q1 2024 Earnings Release |
| Today 21:05 | TRANSMEDICS GROUP, INC.: Q1 2024 Earnings Release |
| 01/05/2024 | INMODE LTD.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BRUKER CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | HOLOGIC, INC.: Q2 2024 Earnings Release |
| 02/05/2024 21:05 | LEMAITRE VASCULAR, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | ILLUMINA, INC.: Q1 2024 Earnings Release |
| 06/05/2024 | QUANTERIX CORPORATION: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 06:00 | SIEMENS HEALTHINEERS AG: Q2 2024 Earnings Release |
| 07/05/2024 11:50 | WATERS CORPORATION: Q1 2024 Earnings Release |
Past sector events for AxoGen, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AXGN Stock
- Calendar AxoGen, Inc.
